Management of High-Grade Upper Tract Urothelial Cell Carcinoma

Rate:
5
added:
4 years ago
views:
751
specialty:
Urology

Case description

Brian W. Cross, MD, assistant professor of urology at the University of Oklahoma, discusses chemotherapy options in patients undergoing nephroureterectomy (NU). He goes on to discuss the advantages of perioperative chemotherapy following NU, the role of neoadjuvant chemotherapy in patients with high-risk upper tract urothelial carcinoma prior to NU, and surgical techniques for the management of the distal ureter during NU.

tags: nephroureterectomy high-risk upper tract urothelial carcinoma upper tract urothelial carcinoma UTUC neoadjuvant chemotherapy chemotherapy


This user also sharing

Recommended

show more